Wenhui Zhao

Wenhui Zhao

Auto-generated profile, based on publicly available information

Wenhui Zhao

Department of Medical Oncology, Harbin Medical University Cancer Hospital, Harbin, China

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 August 2010 in BMC Cancer
Verified
Journal Article
Open access
PDF file
XHXu Huang
Xu Huang
QZQingyuan Zhang
Qingyuan Zhang
XKXinmei Kang
Xinmei Kang
YSYing Song
Ying Song
WZWenhui Zhao
Wenhui Zhao
Background: Fatigue is prevalent in breast cancer survivors and has profound effects on daily life. The interference of fatigue with endocrine therapy may be difficult to separate. This study investigates the prevalence and severity of fatigue and identifies the demographic, clinical, and lifestyle factors associated with cancer-related fatigue (CRF) in breast cancer patients undergoing endocrine therapy in an urban area. Methods: Women with stage I-IIIA breast cancer were recruited and asked to participate (n = 371) in the study. The 315 women who responded to the questionnaire (84.9%), 54 (17.1%) had completed endocrine therapy and 261 (82.9%) were still undergoing endocrine therapy. The patients had been diagnosed at an average of 31 months prior to recruitment (range, 7 to 60 months); the average age was 48 (range, 33 to 72) years. The 11-point scale and Visual Analog Scale (VAS) were employed to quantify the level of fatigue experienced by the patients. Logistic regression analyses and a trend test method were performed to evaluate factors associated with CRF. Results: Among the 315 patients, 189 (60%) had experienced or were experiencing CRF during endocrine therapy. Logistic regression analysis was performed to identify factors associated with CRF, including BMI (body mass index), clinical stage, menopausal status, duration of endocrine therapy, physical activity, and diet. Factors unrelated to CRF were age, marital status, treatment, endocrine therapy drugs, alcohol intake, and smoking. The trend test method revealed an association between physical activity and dietary level and the intensity of CRF. Conclusions: The present findings suggest that fatigue is an important problem in the majority of breast cancer patients during endocrine therapy. We found that BMI, clinical stage, menopausal status, duration of endocrine therapy, physical activity, and diet are associated with fatigue. Future research should focus on the impact factors of CRF and lifestyle in the management of breast cancer patients.

1 October 2014 in European Journal of Endocrinology
Verified
Journal Article
Closed access
ZWZhao Wenhui
Zhao Wenhui
LSLi Shuo
Li Shuo
TDTang Dabei
Tang Dabei
PYPiao Ying
Piao Ying
WZWang Zhipeng
Wang Zhipeng
QZQingyuan Zhang
Qingyuan Zhang
Objective: Androgen receptor (AR) plays an important role in male breast cancer (MBC). Additionally, endocrine therapy is the most important treatment in oestrogen receptor (ER)-positive advanced breast cancer. This study was aimed to investigate the role of AR in MBC treatment and prognosis and to analyse the relationship between AR and the effect of tamoxifen treatment in MBC patients.Methods: AR protein levels and other tumour characteristics (e.g. expression of ER (ESR1), PR (PGR), AR, HER2 (ERBB2) and Ki-67 (MKI67)) in breast cancer tissue from 102 MBC patients were determined using immunohistochemical analysis. Additionally, the relationship between AR status and clinicopathological features was analysed using the χ2-test. Association with survival was initially analysed using the Kaplan–Meier method and the log-rank test, and Cox regression analysis was used to adjust for other prognostic indicators.Results: High expression of AR was not correlated with T-stage, histological grade, HER2 status and the status of other sex hormone receptors, but was associated with lymph node metastases (P=0.032). AR-positive patients showed significantly shorter 5-year overall survival (OS) rates (P=0.045) and 5-year disease-free survival (DFS) rates (P=0.026) than AR-negative patients. By contrast, for patients who received tamoxifen therapy, AR-negative patients showed a higher clinical benefit rate than AR-positive patients (P=0.025). Additionally, the median TTP and OS were significantly different (P=0.02 for TTP; P=0.029 for OS).Conclusions: AR expression correlates strongly with both OS and DFS in patients with MBC. AR-positive patients can predict a poorer clinical outcome than AR-negative patients after adjuvant tamoxifen therapy.

27 May 2014 in Medical Oncology
Verified
Journal Article
Closed access
PDF file
DTDabei Tang
Dabei Tang
YPYing Piao
Ying Piao
SZShu Zhao
Shu Zhao
XMXudong Mu
Xudong Mu
SLShuo Li
Shuo Li
QZQingyuan Zhang
Qingyuan Zhang

1 January 2020 in Journal of Breast Cancer
Verified
Journal Article
Open access
LHLan Huang
Lan Huang
GLGuohua Liang
Guohua Liang
QZQingyuan Zhang
Qingyuan Zhang
WZWenhui Zhao
Wenhui Zhao
Huang L, et al. J Breast Cancer. 2019 Nov;23:e10. https://doi.org/10.4048/jbc.2020.23.e10

21 February 2022 in Journal of Oncology
Verified
Journal Article
Open access
PDF file
WZWenhui Zhao
Wenhui Zhao
XZXinshu Zhu
Xinshu Zhu
QJQiu Jin
Qiu Jin
BLBo Lin
Bo Lin
RJRunyuan Ji
Runyuan Ji
Background. Prostate cancer (PCa) is one of the most common malignancies in men. Increasing evidence has demonstrated that dysregulation of long noncoding RNAs (lncRNAs) is closely related to carcinogenesis and cancer progression. lncRNA NEAT1 has recently been identified as a carcinogenic regulator of multiple cancers; however, the role of NEAT1 on PCa is still poorly understood. Methods. KaplanMeier was conducted to determine the overall survival rate in PCa patients with aberrant NEAT1 levels. qRT-PCR analysis was performed to detect expressions of NEAT1 and miR-766-5p in tissues and cells. In addition, CCK-8, colony formation, flow cytometry analysis, wound healing, and transwell assay were conducted to determine cell proliferation, cell arrest, apoptosis, migration, and invasion. The western blot assay was utilized to determine E2F3 and cell growth-related proteins. The relationship between NEAT1 and miR-766-5p or miR-766-5p and E2F3 was verified by correlation analysis and dual-luciferase reporter assay. Results. Here, we find that NEAT1 is overexpressed in PCa tissues and cell lines. Besides, silencing of NEAT1 inhibits cell proliferation, invasion, and migration and promotes cell apoptosis and cell cycle arrest. Further mechanistic studies find that NEAT1 sponges miR-766-5p, and miRNA-766-5p is negatively correlated with the expression of NEAT1. In addition, the functional experiment shows that upregulation of miRNA-766-5p inhibits PCa proliferation, migration, and invasion. Furthermore, E2F transcription factor 3 (E2F3) is testified to be the downstream target gene of miRNA-766-5p. Finally, the rescue experiment revealed that miRNA-766-5p inhibition largely restores NEAT1 downregulation-mediated function on PCa progression, while E2F3 knockdown partly removes the effects of miRNA-766-5p inhibitor. Conclusions. In conclusion, NEAT1 facilitates PCa progression by targeting the miRNA-766-5p/E2F3 axis.

15 May 2020 in Medicine
Verified
Journal Article
Open access
RMRui Ma
Rui Ma
YLYan Li
Yan Li
SLSongjiang Liu
Songjiang Liu
WZWenhui Zhao
Wenhui Zhao
Background: Hiccups are involuntary contractions of the diaphragm and intercostal muscles, which lead to sudden contractions of the glottis. CAM, such as acupuncture is commonly used and stimulation of the vagus nerve and interference with phrenic nerve conduction are also used to treat hiccups. However, there is little evidence on the effectiveness of acupuncture for cancer-related hiccups. We will plan to conduct a systematic review and meta-analysis of RCTs to evaluate the current evidence on the effects of acupuncture for cancer-related hiccups. Method: The following databases will be searched: PubMed, the Cochrane Library, Wanfang Data, China National Knowledge Infrastructure (CNKI), SinoMed, VIP, Medline, Embase, and EI. Randomized controlled trials will be included to evaluate the effect and safety of acupuncture on cancer patients with hiccups. We will set standards for the curative effect on the basis of the standard of cure and improvement for clinical disease diagnoses. The risk of bias will be assessed by the Cochrane risk of bias tool. We will conduct a meta-analysis and sensitivity analysis, as well as a subgroup analysis if high heterogeneity is present, using Revman 5.3. We will use funnel plots to identify potential reporting biases. We will test asymmetry using Egger test. The Grading of Recommendations Assessment, Development, and Evaluation (GRADE) will be used to evaluate the quality of evidence. Results: This study will be to assess the effect and safety of acupuncture for cancer-related hiccups. Conclusions: This study will assess the effect of acupuncture for cancer-related hiccups and provide reliable evidence for the choice of treatments.